Potential Savings for Medicare Part D Enrollees Under Proposals to Add a Hard Cap on Out-of-Pocket Spending

Medicare Part D, the outpatient prescription drug benefit for Medicare beneficiaries, provides coverage above a catastrophic threshold for high out-of-pocket drug costs, but there is no cap on total out-of-pocket drug costs that beneficiaries pay each year. Recent legislative proposals would add a cap on out-of-pocket spending under Part D. This analysis focuses on the potential impact of different out-of-pocket spending caps in terms of how many beneficiaries would be affected and how much they could save.

Pharmacy, Free Full-Text

The Inflation Reduction Act Will Save Families Thousands of

Federal Register :: Medicare Program; Maximum Out-of-Pocket (MOOP) Limits and Service Category Cost Sharing Standards

Federal Register :: Medicare Program; Maximum Out-of-Pocket (MOOP) Limits and Service Category Cost Sharing Standards

Federal Register :: Medicare Program; Maximum Out-of-Pocket (MOOP) Limits and Service Category Cost Sharing Standards

Competing Proposals to Reform Medicare Part D - AAF

Health Cost and Affordability Policy Issues and Trends to Watch in 2024 - Peterson-KFF Health System Tracker

What Are the Prescription Drug Provisions in the Inflation

How Will the Prescription Drug Provisions in the Inflation Reduction Act Affect Medicare Beneficiaries?

Changes to Medicare Part D in 2024 and 2025 Under the Inflation Reduction Act and How Enrollees Will Benefit

Medicare Begins to Rein In Drug Costs for Older Americans - The New York Times